Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

ChemoCentryx (CCXI)

ChemoCentryx Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CCXI
DateTimeSourceHeadlineSymbolCompany
25/10/202200:14Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CCXIChemoCentryx Inc
25/10/202200:11Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CCXIChemoCentryx Inc
25/10/202200:10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CCXIChemoCentryx Inc
25/10/202200:09Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CCXIChemoCentryx Inc
25/10/202200:07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CCXIChemoCentryx Inc
25/10/202200:03Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CCXIChemoCentryx Inc
25/10/202200:02Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CCXIChemoCentryx Inc
25/10/202200:02Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CCXIChemoCentryx Inc
24/10/202223:59Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CCXIChemoCentryx Inc
24/10/202223:58Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CCXIChemoCentryx Inc
24/10/202223:58Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CCXIChemoCentryx Inc
20/10/202214:28Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:CCXIChemoCentryx Inc
20/10/202214:27Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:CCXIChemoCentryx Inc
20/10/202214:27Edgar (US Regulatory)Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr)NASDAQ:CCXIChemoCentryx Inc
20/10/202214:20Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CCXIChemoCentryx Inc
20/10/202214:05PR Newswire (US)AMGEN SUCCESSFULLY COMPLETES ACQUISITION OF CHEMOCENTRYXNASDAQ:CCXIChemoCentryx Inc
20/10/202213:41Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:CCXIChemoCentryx Inc
18/10/202221:17Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CCXIChemoCentryx Inc
17/10/202213:30GlobeNewswire Inc.ChemoCentryx Announces Presentations at the 2022 American Society of Nephrology and American College of Rheumatology Annual MeetingsNASDAQ:CCXIChemoCentryx Inc
07/10/202221:36Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CCXIChemoCentryx Inc
05/10/202213:30GlobeNewswire Inc.ChemoCentryx Announces Upcoming Presentations for Orally Administered PD-L1 Inhibitor, CCX559, at the 2022 Society for Immunotherapy of Cancer (SITC) Annual MeetingNASDAQ:CCXIChemoCentryx Inc
20/09/202211:04Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CCXIChemoCentryx Inc
20/09/202211:03Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CCXIChemoCentryx Inc
14/09/202222:32Edgar (US Regulatory)Proxy Statement - Merger or Acquisition (definitive) (defm14a)NASDAQ:CCXIChemoCentryx Inc
12/09/202216:14Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CCXIChemoCentryx Inc
31/08/202222:08Edgar (US Regulatory)Proxy Statement - Merger or Acquisition (preliminary) (prem14a)NASDAQ:CCXIChemoCentryx Inc
24/08/202213:30GlobeNewswire Inc.ChemoCentryx Announces TAVNEOS® (avacopan) Presentations at Upcoming Medical ConferencesNASDAQ:CCXIChemoCentryx Inc
23/08/202211:02Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CCXIChemoCentryx Inc
18/08/202221:49Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CCXIChemoCentryx Inc
09/08/202221:13Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CCXIChemoCentryx Inc
 Showing the most relevant articles for your search:NASDAQ:CCXI